<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04413370</url>
  </required_header>
  <id_info>
    <org_study_id>Dry eye screening system</org_study_id>
    <nct_id>NCT04413370</nct_id>
  </id_info>
  <brief_title>Dry Eye Screening and Referral System</brief_title>
  <official_title>The Development of Artificial Intelligence Dry Eye Screening and Referral System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dry eye is one of the most common ocular surface diseases. Its pathogenic factors are related
      to multiple etiology. Because of the complexity of the pathogenesis of dry eye, the diversity
      of related examinations, and the inconsistency of symptoms and signs of dry eye patients, the
      diagnosis of dry eye has higher requirements on the professional technology and examination
      equipment of ophthalmologists.

      The purpose of this study is to establish a case-control cohort of dry eye patients.
      Multimodal data will be collected from participants, including medical history information,
      ocular surface disease index scale (OSDI), anterior segment photography, and treatment
      outcome of dry eye patients. The correlation between the characteristics of anterior segment
      images and dry eye diagnosis will be explored by artificial intelligence algorithms. The
      purpose of this study was to develop an artificial intelligence dry eye screening and
      referral system.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 6, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 6, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Area under the curve (referral)</measure>
    <time_frame>up to 1 month</time_frame>
    <description>AUC values for predicting whether subject need to be referral or not.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Area under the curve (each group)</measure>
    <time_frame>up to 1 month</time_frame>
    <description>AUC values for predicting whether subject can be accurately grouped into each of the four groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accuracy, true positive rate, and true negative rate</measure>
    <time_frame>up to 1 month</time_frame>
    <description>The performance of this artificial platform.</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Dry Eye</condition>
  <arm_group>
    <arm_group_label>Referral Group (no MGD)</arm_group_label>
    <description>This group of subjects was diagnosed with dry eye (without meibomian gland dysfunction) and need to be a referral to the hospital for further treatments.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Referral Group (MGD)</arm_group_label>
    <description>This group of subjects was diagnosed with meibomian gland dysfunction and need to be a referral to the hospital for further treatments.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Artificial tears group</arm_group_label>
    <description>This group of subjects was diagnosed with dry eye but can use artificial tears instead of further treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal control Group</arm_group_label>
    <description>This group of subjects had no dry eye symptoms and signs and belonged to the normal control group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Dry eye diagnostic test</intervention_name>
    <description>The artificial intelligent dry eye screening platform</description>
    <arm_group_label>Artificial tears group</arm_group_label>
    <arm_group_label>Normal control Group</arm_group_label>
    <arm_group_label>Referral Group (MGD)</arm_group_label>
    <arm_group_label>Referral Group (no MGD)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who are equal or over 18 years old with or without dry eye symptoms and signs.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects whose age are greater than or equal to 18 years old;

          2. Subjects who can cooperate with the inspection;

          3. Subjects who agree to participate in the study and sign the consent form.

        Exclusion Criteria:

          1. Subjects who cannot do the inspection.

          2. Subjects who suffer from diseases that compromise the inspection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xun Wang, M.D., Ph.D</last_name>
    <phone>+8615017541549</phone>
    <email>wangx48@mail2.sysu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Haotian Lin, M.D., Ph.D</last_name>
    <phone>+8613802793086</phone>
    <email>haot.lin@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510632</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xun Wang, Ph.D</last_name>
      <phone>+8615017541549</phone>
      <email>wangx48@mail2.sysu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 28, 2020</study_first_submitted>
  <study_first_submitted_qc>May 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2020</study_first_posted>
  <last_update_submitted>May 28, 2020</last_update_submitted>
  <last_update_submitted_qc>May 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Haotian Lin</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

